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Abstract
Background: Ultraviolet (UV) light exposure has been one of the major inducers of apoptosis. UV exposure has caused pyrimidine dimers 
and DNA fragmentation which might lead to cell cycle arrest and apoptosis signals activation. UV induced apoptosis has investigated in 
MDA-MB 468 as an ER negative breast adenocarcinoma and MCF-7 as an ER positive breast cancer cell line. Apoptosis induction rate by UV 
might be different in these two types of cells due to different biological characteristics of the cell.
Objectives: In this paper we have evaluated serial dose of UV-B exposure on ER positive and ER negative breast cancer cell lines and its 
effect on apoptosis or necrosis induction in these cells.
Materials and Methods: MDA-MB468 and MCF-7 cell lines have cultured for 24 hours and UV exposure has carried out at 290 nm at dose 
of 154 J/m2 to 18 KJ/m2 using UV lamp. UV exposed cells have incubated in cell culture condition for 24 or 48 hours following UV exposure 
and the cells have stained and analyzed by flow cytometry for apoptosis evaluation by Annexin V/PI method.
Results: Apoptosis rate (PI and Annexin V double positive cells) after 24 hours incubation was higher in 24 hours in comparison with 48 
hours incubation in both cell lines. The frequency of PI positive MDA-MB 468 cells was higher than PI and Annexin V double positive cells 
after 48 hours. PI positive MDA-MB 468 cells were significantly higher than MCF-7 cells in 24 hours incubation time.
Conclusions: The results have shown that MDA-MB 468 cells were more sensitive to UV exposure and DNA fragmentation and necrosis 
pathway was dominant in these cells.
Keywords: Apoptosis, UV Exposure, ER Positive, Cell Line, ER Negative
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1. Background
Proliferation and prognosis of human breast cancer has 
been dependent on several factors such as their hormone 
or estrogen-responsiveness, expression of estrogen re-
ceptor (ER) and other genes. Hormone-independent (ER 
negative) tumors were more aggressive and develop-
ment of clinical protocols for treatment of these highly 
invasive breast tumors has been a major challenge in 
hormone therapy or chemotherapy protocols (1). Es-
trogen-responsive and hormone-independent human 
breast cancer cell lines and in vivo animal models have 
extensively used for studying the factors responsible for 
cell growth, differentiation and  finally developing new 
strategies for inducing programmed cell death or study-
ing about breast cancer pathogenesis and treatment (2).
Breast cancer cell lines have classified in 5 sub type; 
Laminal A, Laminal B, Basal, ERB2 positive and normal 
breast like cells that these were different with each other 
by estrogen receptor (ER), progesterone receptor (PR) 
ERBb2, Her2neu expression panel (3).
Estrogen independent cell lines such as Hs578T, MDA-
MB-231, MDA-MB 435 and MDA-MB468 were aggressive 
and high metastatic (4) and isolated from high grade tu-
mors (5), The cell cycle period in these cell lines was much 
shorter and aneuploidy disorders were common (6). ER 
negative tumors were resistant to endocrine therapy and 
chemotherapy protocols (7).
Estrogen dependent cell lines such as MCF-7, BT474, 
T47-D, 600MPE and ZR-75-I have isolated from invasive or 
primary ductal or adenocarcinoma tumoral samples (3). 
Differentiation capability, chemotherapy and endocrine 
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therapy responsiveness and disease prognosis in animal 
models in ER positive cell lines was better than ER negative 
cell lines. ER/PR-positive breast cancer tumors were 60% 
likely to respond to endocrine therapy. Tamoxifen, Fares-
ton, Arimidex, Aromasin, Femara, Zoladex/Lupron, Megace 
and Halotestin were some of endocrine therapy drugs (8).
MCF-7 (Michigan cancer foundation-7) has isolated from 
luminal tissue of patient who has suffered adenocarcinoma 
which was ER/PR positive and Her2 negative. MDA-MB468 has 
isolated from basal tissue of patient who had high metastatic 
adenocarcinoma which was ER/PR and Her2 negative (9).
Apoptosis induction was one of the major cell death 
mechanisms that have promoted the suicide of cells, re-
sulting in an advantage, unlike necrosis in cellular im-
mune response. Apoptosis signals activation capability 
was different for types of cells (10). Apoptosis was not the 
main pathway for the death of cancer cells in response 
to common treatment regimens (11), but pro apoptotic 
elements and anti-apoptotic factors had very important 
role in tumorigenesis (12). Malignant cells were hetero-
gene and apoptosis activation pathway has suppressed in 
many types of tumoral cells therefore capability of cells to 
activation of this pathway was very important in tumor 
prognosis (13).
In contrast to apoptosis and autophagy, necrosis has 
considered as an uncontrolled form of cell death. Mor-
phologically, necrosis has characterized by vacuoliza-
tion of the cytoplasm, loss of membrane integrity and 
cellular swelling (14). The resulting release of intracel-
lular components into the microenvironment could 
provoke an inflammatory response. Tumor cell necrosis 
could provoke an inflammatory response, and stimu-
late an immune response towards potentially malig-
nant cells (15). This chemotactic and inflammatory 
response’s function just like tissue damage and bacte-
rial infection that has led to neurotic inflammation 
that cause to release hypoxia, angiogenesis, cell pro-
liferation and cell movement (invasiveness) signaling 
factors (16). Additionally multiple lines of evidence has 
indicated that immune inflammatory cells in necrosis 
path way could led to tumor promoting by production 
of EGF, VEGV, proteases and many types of factors that 
caused to angiogenesis and metastasis (17).
DNA damage caused by UV (Ultra Violet) radiation 
has induced pro apoptotic and cell cycle arrest check-
points expression (18). Low dose of UV-B has caused to 
DNA damage and apoptosis (19), high dose of UV lead to 
necrosis (20). Cell death was strikingly polymorphic; it 
could proceed via necrosis (as in complement-mediated 
cell death) or apoptosis. Capability of apoptosis cascade 
activation was important in immune response recruit-
ment (21, 22).
2. Objectives
In this paper we have evaluated serial dose of UV-B ex-
posure on ER positive and ER negative breast cancer cell 
lines and its effect on apoptosis or necrosis induction in 
these cells.
3. Materials and Methods
Cell culture and irradiation: Human Breast cancer cell 
lines, MCF-7 (C10082) and MDA-MB468 (C10095) have 
purchased from Iranian biological research center 
(IBRC) and have cultured 2D for 24 hours in Dulbecco’s 
modified Eagle medium: Ham’s F12 (DMEM: F12) (Gibco # 
31331 - 028) with 10% heat inactivated Fetal Bovine Serum 
(Gibco # 26140111) and 1% penicillin streptomycin (Gibco 
# 10378032) in 37°C incubator with 5% CO2 cell culture in-
cubator.
UV exposure has carried out using UV laboratory Lamp 
at 290 nm and dose of 154 J/m2 to 18 KJ/m2. Afterwards UV 
exposure, cells have incubated for 24 or 48 hours in 37°C 
incubator with 5% CO2 and 95% of humidity.
3.1. Cell Harvesting and Flow Cytometry
Cell lines have detached by treating with 25% trypsin 
and 5% EDTA and then have washed with phosphate buf-
fer saline (PBS) (Sigma # P4417 - 50TAB).
Apoptosis analysis have carried out in FL2 and FL3 chan-
nels with Cyflow flow cytometry (Partec, Germany) after 
FITC labeled Annexin V and PI (Ebioscience # 88 - 8005 - 
72) staining, 20 minutes in dark condition (Figure 1).
4. Results
4.1. Evaluation of Post UV Exposure Incubation Time has Effected on Apoptosis Rate
MCF-7 cells and MDA-MB468 harvested after 24 or 48 
hours of UV exposure and analyzed by flow cytometry af-
ter staining with PI and Annexin V (Figure 2).
The percent of double positive population in both of cell 
lines after 24 hours incubation was more than 48 hours 
and the percent of double positive population for MCF-
7 cell line after 24 hours was significantly higher than 48 
hours in comparison with MDA-MB468 cell line (Figure 3).
PI positive cells in two cell lines after 48 hours incubation 
were more than 24 hours incubation. Frequency of PI posi-
tive MDA-MB468 cells were significantly greater than MCF-
7 PI positive cells in both of incubation times (Figure 4).
4.2. Evaluation UV Dose Scaling up Effect on MCF-7 and MDA-MB468 Apoptosis Rate
Apoptosis rate in MCF-7 cells have increased following UV 
exposure in a dose dependent manner and in MDA-MB468 
cells, the percentage of apoptotic cells have not signifi-
cantly affected by different dose of UV (Figure 5, the value 
for control experiments were subtracted from all tests).
Frequency of PI positive MDA-MB468 cells has signifi-
cantly increased in accordance with UV exposure dose. 
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MCF-7 PI positive cells also increased by increasing of UV 
dose exposure however frequency of PI positive MDA-
MB468 cells was significantly more than PI positive MCF-
7 cells (Figure 6, the value for control experiments have 
subtracted from all tests).
4.3. Comparison of Apoptosis and Necrosis in Two Cell Lines
Frequency of the MDA-MB468 necrotic cells in response to 
UV exposure after 24 hours were more than apoptotic MDA-
MB468 cells, and UV dose scaling up has not shown any ef-
fect on apoptosis rate of these cells. The frequency of apop-
totic MCF-7 cells after UV exposure in both incubation times 
were more or equal to PI positive MCF-7 cells (Figure 7).
The rate of apoptosis in MCF-7 cells in both incubations 
times, especially in 24 hours, was greater than MDA-
MB468 cells in the same setting. However PI positive cells 
percentage in MDA-MB468 cells was significantly higher 
than other MCF-7. This might indicate that necrosis path-
way in MDA-MB48 cells and apoptosis pathway in MCF-7 
cells were dominant.
Figure 1. A, MCF-7 Normal Cells; B, MCF-7 UV Exposed Cells After 3 Hours
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Figure 2. Double Staining Flow Cytometry Graph in MCF-7 Cells After 24 
Hours Incubation in 18256J/m2
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Figure 3. Double Positive Staining Results in Two Times (24 - 48 hours) 
Incubation for Two Cell Lines: MDA-MB468 (ER Negative) and MCF-7 (ER 
Positive)
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Figure 4. PI Positive Results in Two Times (24 - 48 hours) Incubation for 
Two Cell Lines: MDA-MB468 (ER Negative) and MCF-7 (ER Positive)
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Figure 5. Evaluation UV Dose Scaling up Effect on MCF-7 (ER Positive) and 
MDA-MB468 (ER Negative) Apoptosis Rate in the Same Time Incubation
90
80
70
60
50
40
30
20
10
0
UV Dose
Ce
ll 
Pe
rc
en
ta
ge
123
2 J/
m2
49
28 
J/m
2
98
56
 J/m
2
182
56
 J/m
2
154
 J/m
2  
30
8 J/
m2
  
MCF - 7 after 48 h
MDA - MB468 after48 h
Figure 6. Evaluation UV Dose Scaling up Effect on MCF-7 (ER Positive) and 
MDA-MB468 (ER Negative) Necrosis Rate in the Same Time Incubation
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Figure 7. Comparison of Apoptosis and Necrosis in Two Cell Lines, PI-DP: 
PI Positive Cells Without Double Positive, DP: AnnexinV and PI Positive Cell 
Population
5. Discussion
Ultraviolet radiation-induced apoptosis has mediated 
by activation of CD95 (23) and Fas pathway activation by 
UV is a feasible model for induction of apoptosis in ma-
lignant cells. On the other hand cytotoxic T lymphocytes 
and natural killer (NK) cells have killed target cells such 
as tumor cells by two main mechanisms, namely, the 
perforin/granzymes and the Fas ligand (Fas-L) apoptosis 
pathways (24). UV irradiation-induced apoptosis of mam-
malian cells has associated with two key signaling cas-
cades due to activation of cell surface receptors such as 
the Fas and TNF receptors (25, 26). This has included the 
Fas-FADD-caspase-8-axis and the Jun N-terminal kinase 
(JNK) cascade. Both of these signaling events have re-
quired for the initiation of the apoptotic machinery (27).
There was a good correlation between ER expression 
and FasL pathway in human ER positive cells such as 
monocytes (28), FasL expression has enhanced by estra-
diol “in situ” production from ER positive cells. Although 
FasL has expressed in both of ER positive and ER negative 
cells (29) however, apoptosis induction by TRAIL pathway 
in ER negative cells was more effective (30). ER expression 
and autocrine estrogen production or treatment by es-
tradiol increase apoptosis rate in many types of ER posi-
tive cancers (31). In a similar study on human lympho-
cytes, necrosis and apoptosis induction have assayed by 
flow cytometry after UV exposure and results have shown 
high dose of UV exposure cause necrosis and apoptosis 
signaling activation started after first hours of UV expo-
sure (20). Our data has shown that cell cycle period of ER 
negative cells was shorter than ER positive cells and its 
sensitivity to UV exposure was different in comparison 
with ER positive cell line, This might be in accordance 
with tumor cell behavior in vivo, considering the fact 
that the ER negative cancers were often more aggressive 
and nonresponsive to chemotherapy (7) and these were 
more metastatic than ER positive cells.
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If the necrosis pathway was predominant in these cells 
and apoptosis signals was low or lower than ER positive 
cells this could explain the differences in immune patho-
genesis of breast cancer in ER positive and ER negative cells.
Microenvironment of necrotic cells could be differ-
ent from apoptotic cells. This difference could affect “T 
helper” responses, and natural immune system recruit-
ment has shown different manner. The type of microen-
vironment might play an important role in fate of cancer 
and anti cancer cell immune response interaction as has 
shown in colorectal cancer that necrosis was predomi-
nant in poor differentiated colorectal carcinoma and  tu-
mors with high necrotic cells frequency has shown very 
poor prognosis (32).
In conclusion UV exposure was a simple model for apop-
tosis and necrosis pathway study. We have compared two 
cell line responses to same dose of UV exposure in ER 
positive and negative cell lines in this study. Apoptosis 
pathway activation in ER positive cells was dominant 
in comparison with ER negative cell line. The difference 
could be due to early activation of apoptosis pathway in 
ER positive cells, in comparison with ER negative cells 
which needs further investigation.
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